| Dr Joseph G Barone, MD | |
|
125 Paterson St, Clinical Academic Building - Suite 4100, New Brunswick, NJ 08901-1962 | |
| (732) 235-7776 | |
| Not Available |
| Full Name | Dr Joseph G Barone |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 37 Years |
| Location | 125 Paterson St, New Brunswick, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871662676 | NPI | - | NPPES |
| 6111904 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | MA52755 (New Jersey) | Secondary |
| 208800000X | Urology | 25MA05275500 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rutgers Health-rwj Neurosurgery Faculty | 4587613443 | 95 |
News Archive
IpAuctions™ has scheduled a live international corporate sale of the extensive IP portfolio of pouchless ostomy management technologies owned by Zassi Holdings, Inc. Zassi, the Florida-based firm, fosters breakthrough medical devices that are materially evolving the life sciences industry.
The fragrance of hot pumpkin pie can bring back pleasant memories of holidays past, while the scent of an antiseptic hospital room may cause a shudder. The power of odors to activate memories both pleasing and aversive exists in many animals, from humans to the humble fruit fly.
The Royal Hospital for Women Foundation (RHWF) with the support of celebrity ‘Royal' Mum Ambassadors, has launched its new Mother's Day campaign, Me2Mum, where the gift of a flower will help raise vital funds for care of newborn babies and Mums at NSW's only hospital for women.
The full implementation of traditional public health control strategies and integration of new regulatory authorities has the potential to significantly reduce tobacco-related deaths in the U.S., according to experts at the George Washington University School of Medicine and Health Sciences and the Center for Tobacco Products at the Food and Drug Administration.
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.
› Verified 6 days ago
| Entity Name | Rutgers Health-rwj Surgical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710012604 PECOS PAC ID: 8224017322 Enrollment ID: O20040714000147 |
News Archive
IpAuctions™ has scheduled a live international corporate sale of the extensive IP portfolio of pouchless ostomy management technologies owned by Zassi Holdings, Inc. Zassi, the Florida-based firm, fosters breakthrough medical devices that are materially evolving the life sciences industry.
The fragrance of hot pumpkin pie can bring back pleasant memories of holidays past, while the scent of an antiseptic hospital room may cause a shudder. The power of odors to activate memories both pleasing and aversive exists in many animals, from humans to the humble fruit fly.
The Royal Hospital for Women Foundation (RHWF) with the support of celebrity ‘Royal' Mum Ambassadors, has launched its new Mother's Day campaign, Me2Mum, where the gift of a flower will help raise vital funds for care of newborn babies and Mums at NSW's only hospital for women.
The full implementation of traditional public health control strategies and integration of new regulatory authorities has the potential to significantly reduce tobacco-related deaths in the U.S., according to experts at the George Washington University School of Medicine and Health Sciences and the Center for Tobacco Products at the Food and Drug Administration.
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.
› Verified 6 days ago
| Entity Name | Rutgers Health-rwj Neurosurgery Faculty |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083738637 PECOS PAC ID: 4587613443 Enrollment ID: O20050118000611 |
News Archive
IpAuctions™ has scheduled a live international corporate sale of the extensive IP portfolio of pouchless ostomy management technologies owned by Zassi Holdings, Inc. Zassi, the Florida-based firm, fosters breakthrough medical devices that are materially evolving the life sciences industry.
The fragrance of hot pumpkin pie can bring back pleasant memories of holidays past, while the scent of an antiseptic hospital room may cause a shudder. The power of odors to activate memories both pleasing and aversive exists in many animals, from humans to the humble fruit fly.
The Royal Hospital for Women Foundation (RHWF) with the support of celebrity ‘Royal' Mum Ambassadors, has launched its new Mother's Day campaign, Me2Mum, where the gift of a flower will help raise vital funds for care of newborn babies and Mums at NSW's only hospital for women.
The full implementation of traditional public health control strategies and integration of new regulatory authorities has the potential to significantly reduce tobacco-related deaths in the U.S., according to experts at the George Washington University School of Medicine and Health Sciences and the Center for Tobacco Products at the Food and Drug Administration.
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.
› Verified 6 days ago
| Entity Name | Rwjbh Observation Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760095806 PECOS PAC ID: 5193137503 Enrollment ID: O20201209000008 |
News Archive
IpAuctions™ has scheduled a live international corporate sale of the extensive IP portfolio of pouchless ostomy management technologies owned by Zassi Holdings, Inc. Zassi, the Florida-based firm, fosters breakthrough medical devices that are materially evolving the life sciences industry.
The fragrance of hot pumpkin pie can bring back pleasant memories of holidays past, while the scent of an antiseptic hospital room may cause a shudder. The power of odors to activate memories both pleasing and aversive exists in many animals, from humans to the humble fruit fly.
The Royal Hospital for Women Foundation (RHWF) with the support of celebrity ‘Royal' Mum Ambassadors, has launched its new Mother's Day campaign, Me2Mum, where the gift of a flower will help raise vital funds for care of newborn babies and Mums at NSW's only hospital for women.
The full implementation of traditional public health control strategies and integration of new regulatory authorities has the potential to significantly reduce tobacco-related deaths in the U.S., according to experts at the George Washington University School of Medicine and Health Sciences and the Center for Tobacco Products at the Food and Drug Administration.
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph G Barone, MD 66 W Gilbert St, 2nd Fl., Tinton Falls, NJ 07701-4947 Ph: (732) 212-0051 | Dr Joseph G Barone, MD 125 Paterson St, Clinical Academic Building - Suite 4100, New Brunswick, NJ 08901-1962 Ph: (732) 235-7776 |
News Archive
IpAuctions™ has scheduled a live international corporate sale of the extensive IP portfolio of pouchless ostomy management technologies owned by Zassi Holdings, Inc. Zassi, the Florida-based firm, fosters breakthrough medical devices that are materially evolving the life sciences industry.
The fragrance of hot pumpkin pie can bring back pleasant memories of holidays past, while the scent of an antiseptic hospital room may cause a shudder. The power of odors to activate memories both pleasing and aversive exists in many animals, from humans to the humble fruit fly.
The Royal Hospital for Women Foundation (RHWF) with the support of celebrity ‘Royal' Mum Ambassadors, has launched its new Mother's Day campaign, Me2Mum, where the gift of a flower will help raise vital funds for care of newborn babies and Mums at NSW's only hospital for women.
The full implementation of traditional public health control strategies and integration of new regulatory authorities has the potential to significantly reduce tobacco-related deaths in the U.S., according to experts at the George Washington University School of Medicine and Health Sciences and the Center for Tobacco Products at the Food and Drug Administration.
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.
› Verified 6 days ago
Dr. Haris Syed Ahmed, M.D. Urology Medicare: Medicare Enrolled Practice Location: 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901 Phone: 732-235-7775 | |
Ronald Morton, Urology Medicare: Not Enrolled in Medicare Practice Location: 125 Paterson St, Clinical Academic Building - Suite 4100, New Brunswick, NJ 08901 Phone: 732-235-7776 | |
Danielle Velez Leitner, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 125 Paterson St Ste 4100, New Brunswick, NJ 08901 Phone: 732-235-7775 | |
Dr. Hari Siva Gurunadha Tunuguntla, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 125 Paterson St, Suite 4100, New Brunswick, NJ 08901 Phone: 732-235-7774 Fax: 732-235-6042 | |
Robert E Weiss, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 125 Paterson St, Clinical Academic Building - Suite 4100, New Brunswick, NJ 08901 Phone: 732-235-7776 Fax: 732-235-6042 | |
Dr. Wayland Jay Wu, M.D. Urology Medicare: Medicare Enrolled Practice Location: 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901 Phone: 732-235-7775 | |
Dr. Ephrem Odoy Olweny, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1 Robert Wood Johnson Pl, Meb 588, New Brunswick, NJ 08901 Phone: 732-235-7775 |